Skip to main content
SpringerLink
Log in

Cystic fibrosis: The ΔF508 mutation does not lead to an exceptionally severe phenotype. A cohort study

  • Medical Genetics
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

In an attenmpt to ascertain a relationship between genotype and phenotype, we studied the pulmonary and nutritional status of 123 cystic fibrosis patients with known genotype at an age of 8.5–10 years. Patients represent a cohort as they are almost all those born and diagnosed in a given area and period. They were followed at a single centre using uniform diagnostic and treatment protocols. Pulmonary and nutritional status of homozygous ΔF508 patients did not differ from that of compound heterozygotes or of patients with other unspecified genotypes. Pulmonary manifestations varied widely in all genotype groups. With the given number of patients, a slightly higher mortality of ΔF508 homozygotes could have been coincidental. We conclude that up to the age of 8.5–10 years the severity of pulmonary lesions and nutritional deficiencies is not related to the ‡F508 mutation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CF:

cystic fibrosis

FEV1 :

forced expiratory volume in is

FVC:

forced vital capacity

PI:

pancreas insufficient

PS:

pancreas sufficient

References

  1. Barlocco EG, Benettazzo D, Borgo G et al (1987) Historical course of neonatal screening for cystic fibrosis in Veneto and surrounding areas. Evaluation over 12.8 years. In: Kuzemko JA, Joint GS (eds) Insights into pediatrics Gardner-Caldwell, Macclesfield, pp 1:5–12

    Google Scholar 

  2. Borgo G, Mastella G, Gasparini P, Zorzanello A, Doro R, Pignatti PF (1990) Panereatic function and gene deletion ‡F508 in cystic fibrosis. J Med Genet 27:665–669

    PubMed  Google Scholar 

  3. Borgo G, Mastella G, Gasparini P, Pignatti PF (1990) Genetic analysis and pancreatic function in cystic fibrosis. Lancet I:1601

    Google Scholar 

  4. Britton JR (1989) Effects of social class, sex and region of residence on age of death for cystic fibrosis. BMJ 298:483–487

    PubMed  Google Scholar 

  5. Campbell P, Philips J, Krishnamani S, et al (1991) Cystic fibrosis: relationship between clinical status and ‡F508 deletion. J Pediatr 118:239–241

    PubMed  Google Scholar 

  6. Chrispin AR, Norman AP (1974) The systematic evaluation of the chest radiograph in CF. Pediatr Radiol 2:101–110

    Article  PubMed  Google Scholar 

  7. Collins FS (1991) The gene two years later: progress and projections. Pediatr Pulmonol [Suppl] 6:61–65

    Google Scholar 

  8. Curtis A, Nelson R, Porteous M (1991) Association of less common cystic fibrosis mutations with a mild phenotype. J Med Genet 28:34–37

    PubMed  Google Scholar 

  9. Danker-Roelse JE, Meerman GJ, Martijn A (1989) Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening. J Pediatr 114:362–367

    PubMed  Google Scholar 

  10. Estivill X, Chillon M, Casals T et al (1989) ‡F508 gene deletion in cystic fibrosis in Southern Europe. Lancet II:1404

    Article  Google Scholar 

  11. Figarella C, Taulier G, Sarles H (1965) Dosage de la chymotrypsine et de la trypsine dans le suc duodénal. Bull Soc Chim Biol 47:679–684

    PubMed  Google Scholar 

  12. Gaskin KJ (1988) The impact of nutrition in cystic fibrosis: a review. J Pediatr Gastroenterol Nutr 7 [Suppl 1]:12–17

    Google Scholar 

  13. Gasparini P, Borgo G, Mastella G, Bonizzato A, Dognini M, Pignatti PF (1992) Nine cystic fibrosis patients homozygous for CFTR nonsense mutation R1162X have mild or moderate lung disease. J Med Genet 29:558–562

    PubMed  Google Scholar 

  14. Hibbert ME, Lannigan A, Landav LI (1989) Lung function values from a longitudinal study of healthy children and adolescents. Pediatr Pulmonol 7:101–109

    PubMed  Google Scholar 

  15. Hudson I, Phelan PD (1987) Are sex, age at diagnosis or mode of presentation prognostic factors for cystic fibrosis? Pediatr Pulmonol 3:288–297

    PubMed  Google Scholar 

  16. Jeejeebhoy KN, Ahmed S, Kozek G, et al (1970) Determinations of fecal fats containing both medium and long chain triglycerides and fatty acids. Clin Biochem 3:157–161

    Article  PubMed  Google Scholar 

  17. Johansen H, Nit M, Hoiby N, et al (1991) Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508. Lancet 337:631–634

    Article  PubMed  Google Scholar 

  18. Kerem BS, Rommens JM, Buchanan A et al (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073–1080

    PubMed  Google Scholar 

  19. Kerem E, Corey M, Kerem BS, et al (1990) The relation between genotype and phenotype in cystic fibrosis⊕nalysis of the most common mutation (‡F508). N Engl J Med 323: 1517–1522

    PubMed  Google Scholar 

  20. Kerem E, Reisman J, Corey M et al (1992) Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326:1187–1191

    PubMed  Google Scholar 

  21. Kristidis P, Bozon D, Corey M, et al (1992) Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 50:1178–1184

    PubMed  Google Scholar 

  22. Mastella G, Barbato G, Trabucchi C et al (1975) The exocrine pancreas in cystic fibrosis. Ital J Pediatr 1:109–130

    Google Scholar 

  23. Nunes V, Gasparini P, Novelli G et al (1991) Analysis of 14 cystic fibrosis mutations in five South European populations Hum Genet 87:737–738

    Article  PubMed  Google Scholar 

  24. Osborne L, Knight D, Santis G, et al (1991) No alternative splicing or stop mutations in homozygous ΔF508 patients with very mild pulmonary disease. Pediatr Pulmonol [Suppl 6] 97:249

    Google Scholar 

  25. Padoan R, Bettinelli ME, Cesana B et al. (1991) Survival in cystic fibrosis. Prognostic factors in the Italian population. Ital J Pediatr 17:669–679

    Google Scholar 

  26. Pederzini F, Faraguna D, Giglio L, et al (1990) Development of a screening system for cystic fibrosis: meconium or blood spot trypsin assay or both? Acta Pediatr Scand 79:935–942

    Google Scholar 

  27. Pignatti PF (1991) Cystic fibrosis gene mutations, and correlations with clinical manifestations. Pathol Biol 39:582–584

    PubMed  Google Scholar 

  28. Riordan JR, Rommens JM, Kerem BS, et al (1989) Identification of the cystic fibrosis gene: cloning and characterisation of complementary DNA. Science 245:1066–1072

    PubMed  Google Scholar 

  29. Rommens JM, Iannuzzi MC, Kerem BS, et al (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1065

    PubMed  Google Scholar 

  30. Rommens JM, Kerem BS, Greer W, et al (1990) Rapid nonradioactive detection of the major cystic fibrosis mutation Am J Hum Gen 46:395–396

    Google Scholar 

  31. Sampé M, Pedron G, Roy-Pernot MP (1979) Auxologie: méthode et séquences. Laboratoires Therapix, Paris

    Google Scholar 

  32. Santis G, Osborne L, Knight R, et al (1990) Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 336:1081–1084

    Article  PubMed  Google Scholar 

  33. Stuhrmann M, Macec M, Reis A, et al (1990) Genotype analysis of cystic fibrosis patients in relation to pancreatic sufficiency. Lancet I:738–739

    Article  Google Scholar 

  34. Warwick WJ (1982) Prognosis for survival with CF: the effects of early diagnosis and CF Center care. Acta Pediatr Scand [Suppl] 301:27

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Regionale Veneto Fibrosi Cistica, Ospedale Civile Maggiore, Piazzale Stefani, I-37126, Verona, Italy

    G. Borgo, G. Cabrini & G. Mastella

  2. Istituto di Scienze Biologiche, Facoltà di Medicina e Chirurgia, Università di Verona, Italy

    P. Gasparini, A. Bonizzato & P. F. Pignatti

  3. Servizio di Genetica medica, I.R.C.C.S.-Ospedale C.S.S.S. Giovanni Rotondo, Foggia, Italy

    P. Gasparini & A. Bonizzato

Authors
  1. G. Borgo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Gasparini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Bonizzato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Cabrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Mastella
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. F. Pignatti
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borgo, G., Gasparini, P., Bonizzato, A. et al. Cystic fibrosis: The ΔF508 mutation does not lead to an exceptionally severe phenotype. A cohort study. Eur J Pediatr 152, 1006–1011 (1993). https://doi.org/10.1007/BF01957227

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01957227

Key words

Search

Navigation